Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
boston blog main
boston top stories
dyne therapeutics
life sciences
metacrine
2
×
national blog main
san diego blog main
san diego top stories
abbvie
allergan aesthetics
alzheimer's disease
amgen
astrazeneca
athira pharma
attralus
biontech
biotech ipos
boehringer ingelheim
boston
boulder/denver blog main
boulder/denver top stories
cancer
cancer drugs
chiesi farmaceutici
cholestatic liver diseases
click therapeutics
clinical trials
covid-19
cullinan oncology
cystic fibrosis
daniel o'day
deals
detroit blog main
detroit top stories
diabetic macular edema
diagnostics
dogma therapeutics
eli lilly
escape bio
What
drug
dyne’s
2
×
acquisitions
biggest
bio
brings
build
buy
ceo
company
company’s
daniel
debut
developing
disorders
dyne
genetic
gilead
ipo
medicines
microbiome
million
moves
muscle
muscular
openly
o’day
pipeline
preclinical
raised
rare
roundup
sciences
scores
seagen
spoken
stage
therapeutics
topped
upsized
Language
unset
Current search:
metacrine
×
dyne’s
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
3 years ago
Dyne’s Upsized IPO Brings In $233M for Muscle Disorders Drug R&D
